To be better at neuroscience, Biogen will invest outside the therapeutic area
Fierce Biotech
by aarmstrong
1d ago
To be better at neuroscience, Biogen will invest outside the therapeutic area aarmstrong Wed, 04/24/2024 - 10:39 ..read more
Visit website
Roche's pipeline rethink hits 20% of new molecules as cancer candidates join discard pile
Fierce Biotech
by ntaylor
1d ago
Roche's pipeline rethink hits 20% of new molecules as cancer candidates join discard pile ntaylor Wed, 04/24/2024 - 04:28 ..read more
Visit website
A reason to fight: Former FDA leader Janet Woodcock inspires 3rd Biotech Sisterhood summit
Fierce Biotech
by gmasson
1d ago
A reason to fight: Former FDA leader Janet Woodcock inspires 3rd Biotech Sisterhood summit gmasson Tue, 04/23/2024 - 18:30 ..read more
Visit website
Endeavor bags $132.5M series C, extending runway for clinical-stage fibrosis drugs through 2026
Fierce Biotech
by mbayer
1d ago
Endeavor bags $132.5M series C, extending runway for clinical-stage fibrosis drugs through 2026 mbayer Tue, 04/23/2024 - 15:54 ..read more
Visit website
Alpine's data room was the most exclusive club in biotech. Then Vertex became the VIP
Fierce Biotech
by aarmstrong
1d ago
Alpine's data room was the most exclusive club in biotech. Then Vertex became the VIP aarmstrong Tue, 04/23/2024 - 11:29 ..read more
Visit website
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail
Fierce Biotech
by gmasson
1d ago
Neurocrine-Takeda med reduces depression severity in phase 2, though analysts ask for more data detail gmasson Tue, 04/23/2024 - 10:44 ..read more
Visit website
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Fierce Biotech
by mbayer
1d ago
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M mbayer Tue, 04/23/2024 - 10:12 ..read more
Visit website
BenevolentAI lays off 30% of staff, exits US site as funding gap looms
Fierce Biotech
by ntaylor
1d ago
BenevolentAI lays off 30% of staff, exits US site as funding gap looms ntaylor Tue, 04/23/2024 - 07:24 ..read more
Visit website
Sanofi pulls off phase 3 LUNA landing, sparking race to regulators for BTK inhibitor
Fierce Biotech
by ntaylor
1d ago
Sanofi pulls off phase 3 LUNA landing, sparking race to regulators for BTK inhibitor ntaylor Tue, 04/23/2024 - 02:24 ..read more
Visit website
Vertex has top orphan asset in the pipeline, as pharma eyes shiny obesity drugs: report
Fierce Biotech
by aarmstrong
1d ago
Vertex has top orphan asset in the pipeline, as pharma eyes shiny obesity drugs: report aarmstrong Mon, 04/22/2024 - 23:07 ..read more
Visit website

Follow Fierce Biotech on FeedSpot

Continue with Google
Continue with Apple
OR